Related references
Note: Only part of the references are listed.PINK1 Heterozygous Mutations Induce Subtle Alterations in Dopamine-Dependent Synaptic Plasticity
Graziella Madeo et al.
MOVEMENT DISORDERS (2014)
Parkinson disease: from pathology to molecular disease mechanisms
David T. Dexter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
David N. Hauser et al.
NEUROBIOLOGY OF DISEASE (2013)
Mitochondrial Fission, Fusion, and Stress
Richard J. Youle et al.
SCIENCE (2012)
Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease A Review of Symptomatic and Potential Disease-Modifying Effects
Anthony H. V. Schapira
CNS DRUGS (2011)
Mechanisms of mitophagy
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Electrophysiological effects of trace amines on mesencephalic dopaminergic neurons
Ada Ledonne et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2011)
Physiology of repetitive transcranial magnetic stimulation of the human brain
Janna Marie Hoogendam et al.
BRAIN STIMULATION (2010)
Caspase-3 Activation via Mitochondria Is Required for Long-Term Depression and AMPA Receptor Internalization
Zheng Li et al.
CELL (2010)
Distinct Levels of Dopamine Denervation Differentially Alter Striatal Synaptic Plasticity and NMDA Receptor Subunit Composition
Vincent Paille et al.
JOURNAL OF NEUROSCIENCE (2010)
Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit
C. Eggers et al.
NEUROLOGY (2010)
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Derek P. Narendra et al.
PLOS BIOLOGY (2010)
Synaptic Mechanisms for Plasticity in Neocortex
Daniel E. Feldman
Annual Review of Neuroscience (2009)
Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function
Vanessa A. Morais et al.
EMBO MOLECULAR MEDICINE (2009)
Mapping Preclinical Compensation in Parkinson's Disease: An Imaging Genomics Approach
Bart F. L. van Nuenen et al.
MOVEMENT DISORDERS (2009)
Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype
B. F. L. van Nuenen et al.
NEUROLOGY (2009)
Subclinical sensory abnormalities in unaffected PINK1 heterozygotes
Mirta Fiorio et al.
JOURNAL OF NEUROLOGY (2008)
Motor Cortical Physiology in Patients and Asymptomatic Carriers of Parkin Gene Mutations
Susanne A. Schneider et al.
MOVEMENT DISORDERS (2008)
Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice
Tohru Kitada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
Christine Klein et al.
LANCET NEUROLOGY (2007)
Dopamine-mediated regulation of corticostriatal synaptic plasticity
Paolo Calabresi et al.
TRENDS IN NEUROSCIENCES (2007)
Striatal synaptic plasticity: Implications for motor learning and Parkinson's disease
A Pisani et al.
MOVEMENT DISORDERS (2005)
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation
NL Khan et al.
NEUROLOGY (2005)
PINK1 mutations are associated with sporadic early-onset parkinsonism
EM Valente et al.
ANNALS OF NEUROLOGY (2004)
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
V Bonifati et al.
SCIENCE (2003)
Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism:: An 18F-dopa PET study
NL Khan et al.
ANNALS OF NEUROLOGY (2002)
Progression of nigrostriatal dysfunction in a parkin kindred:: an [18F] dopa PET and clinical study
NL Khan et al.
BRAIN (2002)
Share Paper
